Skip to content
Contact
About PORTAL
Our Team
Our Work
Innovation Incentives and Competition
Regulation and Clinical Evidence
Price, Value, and Access
Search Our Library
Content Type:
Commentary & Opinion
HOME
/
Commentary & Opinion
Recalibrating Privacy Protections to Promote Patient Engagement
March 16, 2026
High-Cost Generic Drugs—Implications for Patients and Policymakers
March 16, 2026
Prescription Trends—Brand-Name Drugs vs Generic (Reply)
March 16, 2026
Insulin Patents and Market Exclusivities: Unresolved Issues (Reply)
March 16, 2026
Information Transparency in the Drug Approval Process (Reply)
March 16, 2026
High-Cost Generic Drugs—Implications for Patients and Policymakers (Reply)
March 16, 2026
Burden of Changes in Generic Pill Appearance (Reply)
March 16, 2026
New FDA Breakthrough-Drug Category—Implications for Patients (Reply)
March 16, 2026
Over-The-Counter Availability of Rescue Inhalers for Asthma (Reply)
March 16, 2026
The 21st Century Cures Act—Will It Take Us Back in Time? (Reply)
March 16, 2026
Regulation of Drugs for Early Alzheimer’s Disease
March 16, 2026
Recent Trends in Prescription Drug Launch Prices (Reply)
March 16, 2026
Posts navigation
«
1
…
6
7
8
9
10
…
39
»